A study at Istanbul University—Cerrahpasa Hospital in Turkey by Ipekci et al. [62] showed that serum samples from COVID-19 patients had significantly lower ACE2 levels than controls and increased Ang II levels. Here, ACE2 is linked to COVID-19.